Atıf İçin Kopyala
Ozdilli K., OĞUZ F., Anak S., ÖGRET Y., Ciftci H. S., Oguz R., ...Daha Fazla
MEDICAL JOURNAL OF BAKIRKOY, cilt.17, sa.4, ss.280-285, 2021 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
17
Sayı:
4
-
Basım Tarihi:
2021
-
Doi Numarası:
10.4274/bmj.galenos.2021.41636
-
Dergi Adı:
MEDICAL JOURNAL OF BAKIRKOY
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.280-285
-
Anahtar Kelimeler:
HLA, GVHD, leukemia, HSCT, HLA CLASS-I, MARROW TRANSPLANTATION, ASSOCIATION, DONOR, RISK
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Objective: Hematopoietic stem cell transplantation (HSCT) is an important therapy for hematological diseases. One of the most significant complications of HSCT is graft versus host disease (GVHD), and major histocompatibility complex (MHC) is well known to affect GVHD and graft rejection. This study aimed to examine the effect of human leukocyte antigens (HLA) on the incidence of GVHD development in patients with leukemia.